IL259557A - Methods for the preparation of modified 6,5-dihydro-6-phenyl-benzo[f]isoquinoline-2-amine - Google Patents

Methods for the preparation of modified 6,5-dihydro-6-phenyl-benzo[f]isoquinoline-2-amine

Info

Publication number
IL259557A
IL259557A IL259557A IL25955718A IL259557A IL 259557 A IL259557 A IL 259557A IL 259557 A IL259557 A IL 259557A IL 25955718 A IL25955718 A IL 25955718A IL 259557 A IL259557 A IL 259557A
Authority
IL
Israel
Prior art keywords
phenylbenzo
isoquinolin
dihydro
amine
methods
Prior art date
Application number
IL259557A
Other languages
English (en)
Hebrew (he)
Original Assignee
Arqule Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arqule Inc filed Critical Arqule Inc
Publication of IL259557A publication Critical patent/IL259557A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/78Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
    • C07D239/84Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL259557A 2015-12-17 2018-05-23 Methods for the preparation of modified 6,5-dihydro-6-phenyl-benzo[f]isoquinoline-2-amine IL259557A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562268758P 2015-12-17 2015-12-17
PCT/US2016/067161 WO2017106639A1 (en) 2015-12-17 2016-12-16 Methods for preparing substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine

Publications (1)

Publication Number Publication Date
IL259557A true IL259557A (en) 2018-07-31

Family

ID=59057623

Family Applications (1)

Application Number Title Priority Date Filing Date
IL259557A IL259557A (en) 2015-12-17 2018-05-23 Methods for the preparation of modified 6,5-dihydro-6-phenyl-benzo[f]isoquinoline-2-amine

Country Status (16)

Country Link
US (4) US9834519B2 (enExample)
EP (2) EP4015508A1 (enExample)
JP (2) JP6940504B2 (enExample)
KR (1) KR20180085814A (enExample)
CN (2) CN114874149A (enExample)
AU (2) AU2016369520B2 (enExample)
BR (1) BR112018012325A2 (enExample)
CA (1) CA3006077A1 (enExample)
EA (1) EA201891431A1 (enExample)
HK (1) HK1255014A1 (enExample)
IL (1) IL259557A (enExample)
MX (2) MX385672B (enExample)
NZ (1) NZ742785A (enExample)
SG (1) SG11201804601TA (enExample)
TW (1) TWI748972B (enExample)
WO (1) WO2017106639A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX385672B (es) * 2015-12-17 2025-03-18 Arqule Inc Metodos para preparar 5,6-dihidro-6-fenilbenzo[f]isoquinolin-2-amina sustituida.
TWI771280B (zh) 2015-12-17 2022-07-21 美商亞闊股份有限公司 經取代之5,6-二氫-6-苯基苯并[f]異喹啉-2-胺化合物之固體形式
CN110669015A (zh) * 2018-07-03 2020-01-10 上海喀露蓝科技有限公司 一种fgfr抑制剂的制备方法
US10878412B2 (en) * 2019-05-13 2020-12-29 Truist Bank In-line verification of transactions
WO2022053708A1 (en) 2020-09-14 2022-03-17 Basilea Pharmaceutica International AG Pharmaceutical combinations for use in the treatment of gastric adenocarcinoma

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
AU5330698A (en) 1996-12-23 1998-07-17 Celltech Therapeutics Limited Fused polycyclic 2-aminopyrimidine derivatives, their preparation and their use as protein tyrosine kinase inhibitors
GB9713087D0 (en) * 1997-06-20 1997-08-27 Celltech Therapeutics Ltd Chemical compounds
JP4932735B2 (ja) * 2004-12-17 2012-05-16 アムジエン・インコーポレーテツド アミノピリミジン化合物および使用方法
JP2010514810A (ja) 2006-12-29 2010-05-06 ライジェル ファーマシューティカルズ, インコーポレイテッド Axlインヒビターとして有用な置換トリアゾール
GB2449293A (en) * 2007-05-17 2008-11-19 Evotec Compounds having Hsp90 inhibitory activity
ES2554623T3 (es) * 2008-12-30 2015-12-22 Arqule, Inc. Compuestos de 5,6-dihidro-6-fenilbenzo[f]isoquinolin-2-amina sustituida
KR20130105675A (ko) 2010-11-25 2013-09-25 라티오팜 게엠베하 아파티닙의 신규 염 및 다형
WO2012177852A1 (en) * 2011-06-24 2012-12-27 Arqule, Inc Substituted imidazopyridinyl compounds
DK3125936T3 (da) * 2014-03-31 2019-08-05 Debiopharm Int Sa Fgfr-fusioner
MX385672B (es) * 2015-12-17 2025-03-18 Arqule Inc Metodos para preparar 5,6-dihidro-6-fenilbenzo[f]isoquinolin-2-amina sustituida.
TWI771280B (zh) 2015-12-17 2022-07-21 美商亞闊股份有限公司 經取代之5,6-二氫-6-苯基苯并[f]異喹啉-2-胺化合物之固體形式

Also Published As

Publication number Publication date
US9834519B2 (en) 2017-12-05
EP3390368A4 (en) 2019-07-03
AU2021202610A1 (en) 2021-05-27
AU2016369520B2 (en) 2021-02-18
BR112018012325A2 (pt) 2018-12-04
US20200102276A1 (en) 2020-04-02
US20180065937A1 (en) 2018-03-08
CN108602779A (zh) 2018-09-28
CA3006077A1 (en) 2017-06-22
NZ742785A (en) 2023-06-30
MX385672B (es) 2025-03-18
MX2020012771A (es) 2022-10-04
JP2021191782A (ja) 2021-12-16
EP4015508A1 (en) 2022-06-22
HK1255014A1 (zh) 2019-08-02
TW201733992A (zh) 2017-10-01
US20170174637A1 (en) 2017-06-22
JP2018537495A (ja) 2018-12-20
KR20180085814A (ko) 2018-07-27
SG11201804601TA (en) 2018-07-30
TWI748972B (zh) 2021-12-11
US20190241527A1 (en) 2019-08-08
US11279679B2 (en) 2022-03-22
AU2016369520A1 (en) 2018-06-07
EA201891431A1 (ru) 2018-11-30
JP6940504B2 (ja) 2021-09-29
CN114874149A (zh) 2022-08-09
WO2017106639A1 (en) 2017-06-22
AU2021202610B2 (en) 2022-06-02
US10766868B2 (en) 2020-09-08
US10093632B2 (en) 2018-10-09
MX2018007415A (es) 2018-11-09
EP3390368A1 (en) 2018-10-24

Similar Documents

Publication Publication Date Title
ZA201606844B (en) Method for preparing amg 416
ZA201700019B (en) Substituted [1,2,4]triazole compounds
IL255302A0 (en) A process for the preparation of 4-amino-pyridines
EP3321272A4 (en) Method for preparing l-bpa
SI3412648T1 (sl) Postopek za izdelavo 1,1,3,3-tetrakloropropena
IL246923A0 (en) A method for the production of (r)-3,1,1-trimethyl-4-aminoindan
IL250682A0 (en) A method for the preparation of 2'-o-fucosyl lactose
PL3178803T3 (pl) Sposób wytwarzania 2,3,3,3-tetrafluoropropenu
PL2949650T3 (pl) Syntetyczny sposób otrzymywania 1,2-benzoizotiazolin-3-onu
SG11201803584RA (en) 1,4-dicarbonyl-piperidyl derivatives
GB2540428B (en) Process for preparing 3,3,3-trifluoropropene
IL253877A0 (en) Process for preparing 3-chloro-2-vinylphenylsulfonates
HUE054626T2 (hu) Eljárás D-arginil-2,6-dimetil-L-tirozil-L-lizil-L-fenilalaninamid elõállítására
HUE065487T2 (hu) Eljárás 3,3,3-trifluorprop-1-én elõállítására
GB2561089B (en) Process for the preparation of 17beta-hydroxy-des-a-androst-9, 10-en-5-one
ZA201903463B (en) Method for preparing hexadecahydropyrene
IL258217A (en) 2,3,4,5 tetrahydropyridin-6-amine derivatives
EP3201164A4 (en) Processes for preparing 2,5-dichlorophenol
GB201515296D0 (en) Hydrogel compositions, methods for preparing the same and uses thereof
IL253630A0 (en) A process for the preparation of modified phenylisoxazoline derivatives
TWI562978B (en) Method for preparation of 1,4-cyclohexanedialkanol
GB201709297D0 (en) Method for preparing methylprrolidones